Affiliation:
1. From the Pediatric Oncology Unit, Departments of Pathology and Radiotherapy, Melanoma Sarcoma Surgical Unit, and Division of Medical Statistics and Biometry, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
Abstract
Purpose Nonrhabdomyosarcoma soft tissue sarcomas are a heterogeneous group of tumors for which optimal treatment remains controversial. We report on a large group of 182 patients younger than 18 years old treated at a single institution over a 25-year period. Patients and Methods In this relatively homogeneous subgroup of adult-type histotypes, surgery was the mainstay of treatment; radiotherapy was administered to 73 patients, and chemotherapy was administered to 114 patients (70 received chemotherapy as adjuvant therapy). Results Overall survival at 5 years was 89% in patients who underwent complete resection at diagnosis, 79% in patients who had marginal resection, 52% in initially unresected patients, and 17% in patients with metastases at onset. Outcome was unsatisfactory in patients with large and high-grade tumors, even after gross resection; adjuvant chemotherapy seemed to improve the results in this group. Initially unresected patients who responded well to chemotherapy and subsequently underwent complete resection had an event-free survival rate of approximately 70%. The rate of response to chemotherapy was 58%. Conclusion The identification of prognostic variables should enable risk-adapted therapies to be planned. Patients with initially unresectable disease and patients with resected large and high-grade tumors are at high risk of metastases and treatment failure. Although the limits of this retrospective analysis are self-evident, our data would suggest that intensive chemotherapy (with an ifosfamide-doxorubicin regimen) might have a more significant role in these patients than what is generally assumed.
Publisher
American Society of Clinical Oncology (ASCO)
Reference36 articles.
1. Weiss SW, Goldblum JR: General considerations, in Weiss SW, Goldblum JR (eds): Enzinger and Weiss's Soft Tissue Tumors . St Louis, MO, CV Mosby, pp 1,2001-19
2. Miser JS, Pappo AS, Triche TJ, et al: Other soft tissue sarcomas of childhood, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology . Philadelphia, PA, Lippincott Williams & Wilkins, pp 1017,2002-1050
3. Adjuvant Chemotherapy for Adult Soft Tissue Sarcoma: Is There a Standard of Care?
4. Summary of the International Symposium on Childhood Non-Rhabdomyosarcoma Soft-Tissue Sarcomas, Padua, Italy, February 10–12, 1994
5. Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial